Skip to main content
. 2021 Mar 11;11:628807. doi: 10.3389/fonc.2021.628807

Figure 5.

Figure 5

Differences in the frequency of mutated pathways between post-treatment tumor samples of the ABC-type rrDLBCL and GCB-type rrDLBCL. Mutations of genes are aggregated for each pathway and the differences between ABC-type rrDLBCL and GCB-type rrDLBCL are shown for (A) refractory disease and (B) recurred disease.